Alembic Pharmaceuticals Q2 Results
- BSE: 533573
- NSE: APLLTD
- ISIN: INE901L01018
- Sector: Biotechnology & Drugs
BSE
770.00
1.15 (0.15%)
1.15 (0.15%)Volume884.00
Updated: Mon 16 Feb, 2026 | 15:29:53
NSE
770.200.30 (0.04%)
0.30 (0.04%)Volume25.86 K
Updated: Mon 16 Feb, 2026 | 15:25:53
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Quarter ended Sep 25
Note: Comparison is on QoQ basis
Quarterly - Alembic Pharmaceuticals Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 25 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 1,670.53 | 1,503.14 | 11.14% | 1,466.36 | 13.92% |
| Depreciation/ Amortization | 76.07 | 73.77 | 3.12% | 70.51 | 7.89% |
| Operating Income | 239.62 | 207.58 | 15.44% | 181.62 | 31.93% |
| Net Income | 184.72 | 154.37 | 19.66% | 153.40 | 20.42% |
| Other Operating Expenses Total | 641.00 | 599.19 | 6.98% | 588.13 | 8.99% |
| Net Income Before Taxes | 223.72 | 190.10 | 17.69% | 180.42 | 24.00% |
| Total Revenue | 1,910.15 | 1,710.72 | 11.66% | 1,647.98 | 15.91% |
| Selling/ General/ Admin Expenses Total | 437.54 | 422.77 | 3.49% | 391.47 | 11.77% |
| Diluted Normalized EPS | 9.40 | 7.85 | 19.68% | 7.24 | 29.92% |